Dishman Carbogen Amcis Limited — Updates, 07-10-2025: Press Release
07-10-2025 | 08:01 pm
07-10-2025 | 08:01 pm
Dishman Carbogen Amcis's subsidiary, CARBOGEN AMCIS AG, partnered with Celonic Group. This alliance creates a fully integrated Antibody-Drug Conjugate (ADC) development and manufacturing platform, streamlining complex processes and speeding timelines for clients in cancer treatment.
No comments yet. Be the first to comment!
